Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs). We report here the anaesthetic management of a 52 year old patient of Ca Colon w...

Descripción completa

Detalles Bibliográficos
Autores principales: Howbora, Nilanjana, Sonowal, Swaraj J., Borah, Tridip J., Kakati, Sonai D., Das, Anupam, Ninu, Marie, Chintey, Dokne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228853/
https://www.ncbi.nlm.nih.gov/pubmed/37260654
http://dx.doi.org/10.4103/sja.sja_682_22
Descripción
Sumario:Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs). We report here the anaesthetic management of a 52 year old patient of Ca Colon with secondary ovarian and peritoneal deposits. She underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with curative intent. The advent of CRS/HIPEC gives a promising alternative to conventional treatment modalities but comes with numerous challenges to the anesthesiologist—in view of the metabolic and hemodynamic adjustments—and demands training.

Ejemplares similares